Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger A Fleischman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The American Journal of the Medical Sciences|April 17, 2013
Polycythemia vera and the Jak2(V617F) mutation in a case of hereditary spherocytosisRoger A Fleischman
The New England Journal of Medicine|December 3, 2025
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic LeukemiaRoger A Fleischman
The New England Journal of Medicine|March 19, 2020
Essential ThrombocythemiaRoger A Fleischman
Leukemia Research|September 25, 2017
Refractory macrocytic anemias in patients with clonal hematopoietic disorders and isolated mutations of the spliceosome gene ZRSR2Roger A Fleischman, Shannon S Stockton, Christopher R Cogle
British Journal of Haematology|February 14, 2002
Absence of mutations in the HoxA10, HoxA11 and HoxD11 nucleotide coding sequences in thrombocytopenia with absent radius syndromeRoger A Fleischman, Rémi Letestu, Xiafang Mi, et al.
Blood|July 2, 2002
Analysis of the hematopoietic potential of muscle-derived cells in miceHartmut Geiger, Jarrod M True, Barry Grimes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 2, 2018
Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor ImmunitySara S Alhakeem, Mary K McKenna, Karine Z Oben, et al.
Blood|April 27, 2018
Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemiaMary K McKenna, Sunil K Noothi, Sara S Alhakeem, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The American Journal of the Medical Sciences|April 17, 2013
Polycythemia vera and the Jak2(V617F) mutation in a case of hereditary spherocytosisRoger A Fleischman
The New England Journal of Medicine|December 3, 2025
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic LeukemiaRoger A Fleischman
The New England Journal of Medicine|March 19, 2020
Essential ThrombocythemiaRoger A Fleischman
Leukemia Research|September 25, 2017
Refractory macrocytic anemias in patients with clonal hematopoietic disorders and isolated mutations of the spliceosome gene ZRSR2Roger A Fleischman, Shannon S Stockton, Christopher R Cogle
British Journal of Haematology|February 14, 2002
Absence of mutations in the HoxA10, HoxA11 and HoxD11 nucleotide coding sequences in thrombocytopenia with absent radius syndromeRoger A Fleischman, Rémi Letestu, Xiafang Mi, et al.
Blood|July 2, 2002
Analysis of the hematopoietic potential of muscle-derived cells in miceHartmut Geiger, Jarrod M True, Barry Grimes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 2, 2018
Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor ImmunitySara S Alhakeem, Mary K McKenna, Karine Z Oben, et al.
Blood|April 27, 2018
Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemiaMary K McKenna, Sunil K Noothi, Sara S Alhakeem, et al.
Pageof 1